ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102 | -84.8% | 15,264 | -80.8% | 0.01% | -86.6% |
| Q2 2023 | $669 | -27.5% | 79,707 | -14.2% | 0.07% | -26.4% |
| Q1 2023 | $923 | -7.4% | 92,944 | -35.1% | 0.09% | -26.6% |
| Q4 2022 | $997 | -99.8% | 143,208 | +37.9% | 0.12% | +67.6% |
| Q3 2022 | $555,000 | +108.6% | 103,848 | +73.3% | 0.07% | +105.6% |
| Q1 2022 | $266,000 | -47.2% | 59,934 | -52.5% | 0.04% | -42.9% |
| Q4 2021 | $504,000 | -44.4% | 126,114 | +22.1% | 0.06% | -31.5% |
| Q3 2021 | $907,000 | +250.2% | 103,276 | +351.6% | 0.09% | +217.2% |
| Q2 2021 | $259,000 | -38.3% | 22,869 | -62.6% | 0.03% | -58.0% |
| Q4 2020 | $420,000 | +122.2% | 61,220 | +140.1% | 0.07% | +115.6% |
| Q3 2020 | $189,000 | – | 25,503 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
| Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
| Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
| Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
| Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
| Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
| Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
| Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
| APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |